Mesotherapy and phosphatidylcholine injections: historical clarification and review
These plots are presented for transparency, but the results should be interpreted with extreme caution
Weight loss also leads to a decrease in GLP-1 and changes other appetite-related hormones, which can prompt you to eat to get back up to your baseline weight
This article highlights recent developments in GLP-1 agonist formulations and delivery methods, including advanced injectable formulations (eg, prolonged release), novel oral delivery systems (eg, buccal tablets), and topical formulations (eg, transdermal patches)
DiMarchi created new dual agonists, targeting GLP-1 and GIP receptors, and in mice, they found these compounds to be more effective at weight loss than existing drugs that target just GLP-1